1. Medtech Insight
  2. >>Policy & Regulation

AdvaMed: Medtech Needs Voice in Value-Based Health-Care Models

New frameworks issued by the trade group attempt to press the industry's view of "value" and how it should be measured for medical devices.

Value dial

AdvaMed and the UK-based accounting firm Deloitte, released frameworks for "defining value" for medical devices and diagnostics May 15. The frameworks outline, among other issues, what principles and factors should be used to assess the worth of medical technology.

Over the past decade, the US health-care system has rapidly shifted toward a value-based approach, where medical products are more...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Medtech Insight

EU Pilot Features ‘All-In-One’ Regulatory Path For Drug/Diagnostic Trials

 
• By Vibha Sharma

The EU is testing a groundbreaking “all-in-one” process for reviewing combined drug and diagnostic trials via a single application for coordinated assessment.

European Medtechs Reiterate Opposition To Reciprocal Tariffs On US Imports

 
• By Ashley Yeo

EU countermeasures against US tariffs suggest medtech categories exported to the EU could be targeted for tariffs. MedTech Europe and the German IVDs industry have stressed the negative effects this would have on patient care.

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 
• By Natasha Barrow

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.